Trial Profile
The Extension study : Using TOfogliflozin for Possible better Intervention against Atherosclerosis for Type 2 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2022
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Atherosclerosis; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms UTOPIA Ex study
- 17 Nov 2022 Status changed from recruiting to completed.
- 17 May 2018 New trial record